Use of Vasopressors in Septic Shock (VISS) “A Multi-National Survey to Know the Practice Pattern”

---

Original Article

Author Details : Nang Sujali Choupoo*, Astha Guliani, Saurabh Kumar Das, Parveen Kaur

Volume : 1, Issue : 2, Year : 2023

Article Page : 71-74

Suggest article by email

---

Abstract

Objective: Despite the widespread compliance of surviving sepsis guidelines, heterogeneity may exist in clinical practice while using vasopressors in ICU setting. Due to paucity of clear-cut evidences and recommendations in some areas of management of septic shock, this multinational survey was conducted to know how physicians use vasopressors and inotropes to manage patients with septic shock.
Method: The survey consisted of nine questions pertinent to use of vasoactive drugs and one question about country of responder. Data were collected automatically using SurveyMonkey Inc. (www.surveymonkey.com). The survey link (https://www.surveymonkey.com/r/JN5GMPX) was distributed by e-mail, text message, and WhatsApp to qualified medical practitioners that treat critically ill patients.
Results: A total of 142 physicians from ten countries participated in the survey. Majority of the responders start vasopressor before completion of fluid bolus, through a peripheral venous access and use vasopressin infusion as second line vasopressor. But opinions are divided at what dose of norepinephrine infusion, vasopressin and steroid are added and how to de-escalate vasopressor after resolution of septic shock.
Conclusion: This survey reveals that some areas in the management of septic shock need uniformity in clinical practice and require further research.

How to cite : Choupoo N S , Guliani A , Das S K , Kaur P , Use of Vasopressors in Septic Shock (VISS) “A Multi-National Survey to Know the Practice Pattern”. Onco Crit Care 2023;1(2):71-74

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.